We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Healthcare Inv | LSE:HIO | London | Ordinary Share | GB00B94T6Y14 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 14.75 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
TIDMCOS
Collagen Solutions PLC
23 May 2019
23 May 2019
Collagen Solutions plc
("Collagen Solutions" or the "Company")
ShareSoc Growth Company Seminar
Collagen Solutions Plc (AIM: COS), the developer and manufacturer of biomaterials and regenerative medicines for the enhancement and extension of human life, announces it will be presenting at the ShareSoc Growth Company Seminar in Manchester on Tuesday, 4 June 2019.
Jamal Rushdy, CEO, will provide a company overview, highlighting the positive momentum as announced in the April Trading Update as well as plans for future growth.
The event will take place at the DoubleTree by Hilton Hotel, One Piccadilly Place, 1 Auburn Street, Manchester, M1 3DG. Registration will open at 6.00pm.
Further details of the event, along with a registration form, are available at:
https://www.sharesoc.org/events/sharesoc-growth-company-seminar-in-manchester-4-june-2019/
Enquiries:
Collagen Solutions Plc Jamal Rushdy, CEO Via Walbrook Hilary Spence, CFO Cenkos Securities Plc (Nominated Tel: 0207 397 8900 Adviser and Broker) Giles Balleny / Stephen Keys Walbrook PR Ltd Tel: 020 7933 8780 or collagen@walbrookpr.com Anna Dunphy Mob: 07876 741 001 Helen Cresswell Mob: 07841 917 679
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
NRAKMGZKVZDGLZM
(END) Dow Jones Newswires
May 23, 2019 02:01 ET (06:01 GMT)
1 Year Healthcare Inv Chart |
1 Month Healthcare Inv Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
